Movement Disorders (revue) - Checkpoint (Ncbi)

Index « Mesh.i » - entrée « Drug Combinations »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Drug Carriers < Drug Combinations < Drug Costs  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 76.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000064 (1999) M C Prevett [Royaume-Uni] ; M N RossorCentral pontine and extrapontine myelinolysis presenting with parkinsonism in a patient with cystic fibrosis.
000153 (1999) J E Ahlskog [États-Unis] ; R J Uitti ; M K O'Connor ; D M Maraganore ; J Y Matsumoto ; K F Stark ; M F Turk ; O L BurnettThe effect of dopamine agonist therapy on dopamine transporter imaging in Parkinson's disease.
000159 (1999) J. Kimber [Royaume-Uni] ; L. Watson ; C J MathiasNeuroendocrine responses to levodopa in multiple system atrophy (MSA).
000166 (1999) T. Mezaki [Japon] ; R. Kaji ; M F Brin ; M. Hirota-Katayama ; T. Kubori ; T. Shimizu ; J. KimuraCombined use of type A and F botulinum toxins for blepharospasm: a double-blind controlled trial.
000168 (1999) C. Dentresangle [France] ; L. Veyre ; D. Le Bars ; C. Pierre ; F. Lavenne ; P. Pollak ; J. Guerin ; J C Froment ; E. BrousolleStriatal D2 dopamine receptor status in Parkinson's disease: an [18F]dopa and [11C]raclopride PET study.
000200 (2000) L M Shulman [États-Unis] ; A. Minagar ; W J WeinerThe effect of pregnancy in Parkinson's disease.
000676 (2002) Elena Meseguer [Espagne] ; Rocio Taboada ; Vicenta Sánchez ; María Angeles Mena ; Victor Campos ; Justo García De YébenesLife-threatening parkinsonism induced by kava-kava.
000721 (2002) Ruth Djaldetti [Israël] ; Rivkah Inzelberg ; Nir Giladi ; Amos D. Korczyn ; Yehudit Peretz-Aharon ; Martin J. Rabey ; Yuval Herishano ; Silvia Honigman ; Sami Badarny ; Eldad MelamedOral solution of levodopa ethylester for treatment of response fluctuations in patients with advanced Parkinson's disease.
000745 (2002) Ashfaq A. Sharif [États-Unis]Entacapone in restless legs syndrome.
000834 (2002) Miriam Vélez [Pérou] ; Carlos Cosentino ; Luis TorresLevodopa-responsive rubral (Holmes') tremor.
000926 (2002) Marie-Paule Muriel [France] ; Gaël Orieux ; Etienne C. HirschLevodopa but not ropinirole induces an internalization of D1 dopamine receptors in parkinsonian rats.
000927 (2002) Susan H. Fox [Royaume-Uni] ; Brian Henry ; Michael Hill ; Alan Crossman ; Jonathan BrotchieStimulation of cannabinoid receptors reduces levodopa-induced dyskinesia in the MPTP-lesioned nonhuman primate model of Parkinson's disease.
000957 (2002) Theresa A. Zesiewicz [États-Unis] ; Sujatha Borra ; Robert A. HauserClozapine withdrawal symptoms in a Parkinson's disease patient.
000995 (2003) Lisa M. Inkster [Canada] ; Janice J. Eng [Canada] ; Donna L. Macintyre [Canada] ; A. Jon StoesslLeg muscle strength is reduced in PD and relates to the ability to rise from a chair
000B91 (2003) Jau-Shin Lou [États-Unis] ; Greg Kearns ; Theodore Benice ; Barry Oken ; Gary Sexton ; John NuttLevodopa improves physical fatigue in Parkinson's disease: a double-blind, placebo-controlled, crossover study.
000C83 (2004) Connie Marras [Canada] ; Anthony Lang ; Murray Krahn ; George Tomlinson ; Gary NaglieQuality of life in early Parkinson's disease: impact of dyskinesias and motor fluctuations.
000D41 (2004) Michiko K. Bruno [États-Unis] ; Bernard Ravina ; Gaetan Garraux ; Mark Hallett ; Louis Ptacek ; Amanda Singleton ; Janel Johnson ; Andrew Singleton ; Melissa Hanson ; Elaine Considine ; Katrina Gwinn-HardyExercise-induced dystonia as a preceding symptom of familial Parkinson's disease.
000E11 (2004) Norman A. Leopold [États-Unis] ; Marcia Polansky ; Marcia R. HurkaDrug adherence in Parkinson's disease.
000E40 (2004) Judit Horvath [Suisse] ; Robin D. Fross ; Galit Kleiner-Fisman ; René Lerch ; Hans Stalder ; Suzanne Liaudat ; William J. Raskoff ; Keith D. Flachsbart ; Harry Rakowski ; Jean-Claude Pache ; Pierre R. Burkhard ; Anthony E. LangSevere multivalvular heart disease: a new complication of the ergot derivative dopamine agonists.
000E86 (2004) Shih-Ching Wang [Taïwan] ; Guey-Jen Lee-Chen ; Cheng-Kung Wang ; Chiung-Mei Chen ; Lok-Ming Tang ; Yih-Ru WuMarkedly asymmetrical parkinsonism as a leading feature of adult-onset Huntington's disease.
001001 (2004) William Bara-Jimenez [États-Unis] ; Tzvetelina Dimitrova ; Abdulah Sherzai ; Antonella Favit ; M M Mouradian ; Thomas N. ChaseEffect of monoamine reuptake inhibitor NS 2330 in advanced Parkinson's disease.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Ncbi/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Mesh.i -k "Drug Combinations" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Mesh.i  \
                -Sk "Drug Combinations" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Ncbi
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Drug Combinations
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024